//
Impact of lesion complexity on peri-procedural adverse events and the benefit of potent intravenous platelet adenosine diphosphate receptor inhibition after percutaneous coronary intervention: core laboratory analysis from 10 854 patients from the CHAMPION PHOENIX trial
Defining Staged Procedures for Percutaneous Coronary Intervention Trials A Guidance Document
Impact of Optimal Medical Therapy on 10-Year Mortality After Coronary Revascularization
In-Hospital Costs and Costs of Complications of Chronic Total Occlusion Angioplasty Insights From the OPEN-CTO Registry
Dynamic atrioventricular delay programming improves ventricular electrical synchronization as evaluated by 3D vectorcardiography
Effects of dapagliflozin on major adverse kidney and cardiovascular events in patients with diabetic and non-diabetic chronic kidney disease: a prespecified analysis from the DAPA-CKD trial
Routinely reported ejection fraction and mortality in clinical practice: where does the nadir of risk lie?
Plaque progression assessed by a novel semi-automated quantitative plaque software on coronary computed tomography angiography between diabetes and non-diabetes patients: A propensity-score matching study